melanoma

FDA approves new melanoma treatments

On Oct. 28, the U.S. Food and Drug Administration (FDA) expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with…

Making a stand against malignant melanoma

Summer sizzles on, sun-worshipers soak up the rays. Years later, your ability to detect melanoma in its early stages could spell the difference between a patient’s prompt treatment…

Mitigating melanoma

Mela­noma, which was once thought to be uncommon, is the most serious type of skin cancer. It accounts for 75% of deaths associated with cutaneous cancers.

Mitigating melanoma

Mela­noma, which was once thought to be uncommon, is the most serious type of skin cancer. It accounts for 75% of deaths associated with…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey

Poll

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.